TY - JOUR
T1 - Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.
AU - Kaas, Bonnie
AU - Huisman, Thierry A.G.M.
AU - Tekes, Aylin
AU - Bergner, Amanda L
AU - Blakeley, Jaishri O.
AU - Jordan, Lori C.
PY - 2013/5
Y1 - 2013/5
N2 - To describe the spectrum and associated clinical features of peripheral and cerebral vasculopathy in pediatric patients with neurofibromatosis type 1, children seen at a single center from 2000 to 2010 with appropriate imaging studies were identified. Scans were assessed for vascular disease by 2 pediatric neuroradiologists. Of 181 children, 80 had pertinent imaging studies: 77 had brain imaging, 6 had peripheral imaging, and 3 had both. Vasculopathy was identified in 14/80 children (18%, minimum prevalence of 14/181; 8%). Of those with vascular abnormalities, 2/14 had peripheral vasculopathy (1% minimum prevalence) and 12/14 had cerebrovascular abnormalities (7% minimum prevalence). No associations were found between vasculopathy and common clinical features of neurofibromatosis type 1, including optic pathway glioma, plexiform neurofibroma, skeletal abnormalities, attention-deficit hyperactivity disorder (ADHD), or suspected learning disability. Both peripheral and cerebral vasculopathy are important complications of pediatric neurofibromatosis type 1 and should be considered in the management of this complex disease.
AB - To describe the spectrum and associated clinical features of peripheral and cerebral vasculopathy in pediatric patients with neurofibromatosis type 1, children seen at a single center from 2000 to 2010 with appropriate imaging studies were identified. Scans were assessed for vascular disease by 2 pediatric neuroradiologists. Of 181 children, 80 had pertinent imaging studies: 77 had brain imaging, 6 had peripheral imaging, and 3 had both. Vasculopathy was identified in 14/80 children (18%, minimum prevalence of 14/181; 8%). Of those with vascular abnormalities, 2/14 had peripheral vasculopathy (1% minimum prevalence) and 12/14 had cerebrovascular abnormalities (7% minimum prevalence). No associations were found between vasculopathy and common clinical features of neurofibromatosis type 1, including optic pathway glioma, plexiform neurofibroma, skeletal abnormalities, attention-deficit hyperactivity disorder (ADHD), or suspected learning disability. Both peripheral and cerebral vasculopathy are important complications of pediatric neurofibromatosis type 1 and should be considered in the management of this complex disease.
UR - http://www.scopus.com/inward/record.url?scp=84885931961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885931961&partnerID=8YFLogxK
U2 - 10.1177/0883073812448531
DO - 10.1177/0883073812448531
M3 - Article
C2 - 22832780
AN - SCOPUS:84885931961
SN - 0309-1708
VL - 28
SP - 561
EP - 569
JO - Unknown Journal
JF - Unknown Journal
IS - 5
ER -